Business / Finance

RSS

Mylan receives $300M committed financing

Mylan Inc. today announced that it has entered into a facility agreement with a syndicate of banks to securitize up to $300 million of U.S. accounts receivable. The facility is committed and has a maturity of three years. The interest rate on any outstanding borrowings will be more than 100 basis points lower than the rate on the company's secured credit facilities.

21 Feb 2012

GTx fourth quarter net loss increases to $10.7 million

GTx, Inc. today provided a Company update and reported financial results for the fourth quarter and full year 2011.

21 Feb 2012

Medco fourth-quarter total net revenues increase 12.2% to record $19.0 billion

Medco Health Solutions, Inc. today reported record fourth-quarter 2011 GAAP diluted EPS of $1.08, an increase of 22.7 percent, which includes expenses associated with the pending merger with Express Scripts, Inc. of $43.6 million before provision for income taxes. When excluding these merger-related expenses, diluted EPS increased 29.5 percent over fourth-quarter 2010.

21 Feb 2012

Cadila Pharmaceuticals to distribute Bactiguard products throughout India

Bactiguard has signed an exclusive co-operation with Cadila Pharmaceuticals, one of the largest healthcare manufacturing groups in India. A signing process will take place at the Swedish Ambassador's residency tonight.

21 Feb 2012

Flaws in ESI-Medco efficiency claims over proposed merger

David A. Balto, an antitrust attorney in Washington and former Policy Director of the Federal Trade Commission, released a white paper today exposing the flaws in efficiency claims made by Express Scripts, Inc. and Medco Health Solutions, Inc. with respect to their proposed merger.

20 Feb 2012

ICA reports a year full of achievements

ICA announced today that 2011 saw strong growth in hospitals and clinics under contract for its CareAlign Solutions suite, as well as significant product upgrades among its current client base. In addition, ICA's employee base again nearly doubled in 2011 to meet growing demand and critical partnerships were formalized.

20 Feb 2012

Mobius selects The Apothecary Shops as distribution partner for Mitosol Kit for Ophthalmic Use

Apothecary Shop Wholesale, Inc., an affiliate of The Apothecary Shops Specialty Pharmacies, has received exclusive distribution rights from Mobius Therapeutics, LLC for its new drug Mitosol (mitomycin for solution) 0.2 mg/vial Kit for Ophthalmic Use.

18 Feb 2012

Provena Health and Resurrection Health Care are now joined as Presence Health

Presence Health has been chosen as the name of the new healthcare system formed by the November 2011 merger of Provena Health of Mokena, IL, and Resurrection Health Care of Chicago, IL. A formal rollout of a new logo and related branding will occur over the next several months.

18 Feb 2012

NASDAQ notifies CytRx of non-compliance with minimum bid price requirement

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that, as anticipated, on February 15, 2012, the Company was notified by The NASDAQ Stock Market that because the Company has not regained compliance with the $1.00 minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2), the Company's common stock would be subject to delisting from The NASDAQ Capital Market unless the Company requests a hearing before a NASDAQ Hearings Panel.

18 Feb 2012

Cardinal Health Canada's offer for Futuremed common shares expires

Cardinal Health Canada Inc., a wholly-owned subsidiary of Cardinal Health, Inc., announced today that the offer by Cardinal Health Canada to acquire all of the outstanding common shares of Futuremed Healthcare Products Corporation for CAD $8.15 per Common Share in cash has expired.

18 Feb 2012

Aptuit sells Clinical Trials Supply business to Catalent Pharma Solutions

Aptuit announces the completion of the sale of the Clinical Trials Supply business to Catalent Pharma Solutions on February 17, 2012. Timothy C. Tyson, Chairman and CEO of Aptuit, LLC stated that Aptuit will continue to deliver scientific and service excellence to provide integrated capabilities for the early to mid phase drug development markets.

18 Feb 2012

Meda's 2011 group net sales increase 18% to SEK 12,856 million

MEDA: Group net sales reached SEK 12,856 million (11,571). At fixed currency rates, sales increased 18%.

18 Feb 2012

Netsmart chooses Overland Park as the location for permanent Kansas office

Netsmart, the leading provider of clinical solutions for health and human services organizations nationwide, today announced it has selected 4950 College Boulevard, Overland Park, Kan., as the location for its permanent Kansas office. Netsmart has named the office the Solutionarium.

18 Feb 2012

Zhejiang Hisun Pharmaceutical, Pfizer sign framework agreement

Pfizer Inc. and Zhejiang Hisun Pharmaceutical, a leading pharmaceutical company in China, today signed a framework agreement, advancing their previously announced memorandum of understanding (MOU) to establish a joint venture to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets.

18 Feb 2012